Fumarate modulates phospholipase A2 receptor autoimmunity-induced podocyte injury in membranous nephropathy-Reference-Cited by-同舟云学术

Fumarate modulates phospholipase A2 receptor autoimmunity-induced podocyte injury in membranous nephropathy

Published:2021-02 Issue:2 Volume:99 Page:443-455
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Jo Hyung Ah,Hyeon Jin Seong,Yang Seung Hee,Jung Youngae,Ha Hunjoo,Jeong Chang Wook,Kwak Cheol,Kim Yaerim,Lee Hajeong,Lee Jung Pyo,Joo Kwon Wook,Lim Chun Soo,Kim Yon Su,Hwang Geum-Sook,Kim Dong Ki

Funder

Korea Basic Science Institute

Ministry of Trade, Industry and Energy

Publisher

Elsevier BV

Subject

Nephrology

Reference45 articles.

1. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy;Beck;N Engl J Med,2009

2. Risk HLA-DQA1 and PLA2R1 alleles in idiopathic membranous nephropathy;Stanescu;N Engl J Med,2011

3. Genetics of membranous nephropathy;Gupta;Nephrol Dial Transplant,2017

4. Genetic basis of autoimmunity;Marson;J Clin Invest,2015

5. Anti-phospholipase A2 receptor antibody titer predicts post-rituximab outcome of membranous nephropathy;Ruggenenti;J Am Soc Nephrol,2015

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Urine Tricarboxylic Acid Cycle Metabolites and Risk of End-stage Kidney Disease in Patients With Type 2 Diabetes;The Journal of Clinical Endocrinology & Metabolism;2024-03-28

2. Mitochondrial fumarate promotes ischemia/reperfusion‐induced tubular injury;Acta Physiologica;2024-02-26

3. Metabolome panels as potential noninvasive biomarkers for primary glomerulonephritis sub-types: meta-analysis of profiling metabolomics studies;Scientific Reports;2023-11-21

4. Lactobacillus species ameliorate membranous nephropathy through inhibiting the aryl hydrocarbon receptor pathway via tryptophan‐produced indole metabolites;British Journal of Pharmacology;2023-09-19

5. Urine myo-inositol as a novel prognostic biomarker for diabetic kidney disease: a targeted metabolomics study using nuclear magnetic resonance;Kidney Research and Clinical Practice;2023-07-31